Zimmer Biomet Holdings Stock Price, News & Analysis (NYSE:ZBH)

$112.24 1.16 (1.04 %)
(As of 11/17/2017 12:19 PM ET)
Previous Close$111.08
Today's Range$110.98 - $112.95
52-Week Range$98.20 - $133.49
Volume1.63 million shs
Average Volume1.37 million shs
Market Capitalization$22.7 billion
P/E Ratio13.77
Dividend Yield0.86%
Beta1.17

About Zimmer Biomet Holdings (NYSE:ZBH)

Zimmer Biomet Holdings logoZimmer Biomet Holdings, Inc. is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products. The Company's products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. The Company manages its operations through three geographic operating segments: the Americas, consisting principally of the United States and other North, Central and South American markets; EMEA, consisting principally of Europe and the Middle East and African markets, and Asia Pacific, consisting primarily of Japan and other Asian and Pacific markets. The Company's product category segments include Americas Spine, Office Based Technologies, Craniomaxillofacial and Thoracic (CMF), and Dental.


Industry, Sector and Symbol:
  • Industry: Medical Equipment, Supplies & Distribution
  • Sub-Industry: N/A
  • Sector: Medical Equipment, Supplies & Distribution - NEC
  • Symbol: NYSE:ZBH
  • Previous Symbol: NYSE:ZMH
  • CUSIP: N/A
  • Web: www.zimmerbiomet.com
Debt:
  • Debt-to-Equity Ratio: 0.88%
  • Current Ratio: 1.47%
  • Quick Ratio: 0.78%
Price-To-Earnings:
  • Trailing P/E Ratio: 13.77
  • Forward P/E Ratio: 13.98
  • P/E Growth: 1.72
Sales & Book Value:
  • Annual Sales: $7.6839 billion
  • Price / Sales: 2.96
  • Cash Flow: $13.52 per share
  • Price / Cash: 8.30
  • Book Value: $51.61 per share
  • Price / Book: 2.17
Dividend:
  • Annual Dividend: $0.96
  • Dividend Yield: 0.9%
Profitability:
  • Trailing EPS: $3.21
  • Net Income: $305.9 million
  • Net Margins: 8.36%
  • Return on Equity: 16.29%
  • Return on Assets: 6.17%
Misc:
  • Employees: 18,500
  • Outstanding Shares: 202,470,000
 
Frequently Asked Questions for Zimmer Biomet Holdings (NYSE:ZBH)

What is Zimmer Biomet Holdings' stock symbol?

Zimmer Biomet Holdings trades on the New York Stock Exchange (NYSE) under the ticker symbol "ZBH."

How often does Zimmer Biomet Holdings pay dividends? What is the dividend yield for Zimmer Biomet Holdings?

Zimmer Biomet Holdings declared a quarterly dividend on Monday, August 7th. Investors of record on Friday, September 22nd will be given a dividend of $0.24 per share on Friday, October 27th. This represents a $0.96 annualized dividend and a dividend yield of 0.86%. The ex-dividend date is Thursday, September 21st. View Zimmer Biomet Holdings' Dividend History.

How were Zimmer Biomet Holdings' earnings last quarter?

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) posted its quarterly earnings results on Wednesday, November, 1st. The medical equipment provider reported $1.72 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.74 by $0.02. The medical equipment provider earned $1.82 billion during the quarter, compared to analyst estimates of $1.83 billion. Zimmer Biomet Holdings had a net margin of 8.36% and a return on equity of 16.29%. The company's revenue was down .8% compared to the same quarter last year. During the same quarter last year, the firm posted $1.79 EPS. View Zimmer Biomet Holdings' Earnings History.

When will Zimmer Biomet Holdings make its next earnings announcement?

Zimmer Biomet Holdings is scheduled to release their next quarterly earnings announcement on Monday, January, 29th 2018. View Earnings Estimates for Zimmer Biomet Holdings.

What guidance has Zimmer Biomet Holdings issued on next quarter's earnings?

Zimmer Biomet Holdings updated its FY17 earnings guidance on Wednesday, November, 1st. The company provided earnings per share guidance of $8.01-$8.07 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $8.23. The company issued revenue guidance of $7.76-$7.80 billion, compared to the consensus revenue estimate of $7.83 billion.Zimmer Biomet Holdings also updated its Q4 guidance to $2.08-$2.14 EPS.

Where is Zimmer Biomet Holdings' stock going? Where will Zimmer Biomet Holdings' stock price be in 2017?

22 brokers have issued 1-year price targets for Zimmer Biomet Holdings' stock. Their predictions range from $92.00 to $158.00. On average, they expect Zimmer Biomet Holdings' share price to reach $135.40 in the next year. View Analyst Ratings for Zimmer Biomet Holdings.

What are Wall Street analysts saying about Zimmer Biomet Holdings stock?

Here are some recent quotes from research analysts about Zimmer Biomet Holdings stock:

  • 1. According to Zacks Investment Research, "Zimmer Biomet ended the third quarter 2017 on a dismal note with earnings below the Zacks Consensus Estimate and revenues in line with the same. Sales were declining within most of the core segments primarily due to the slower pace of supply recovery and sales recapture of certain key brands particularly in the United States and softened domestic market conditions. The lowered 2017 guidance also added to our concerns indicating little chances of recovery ahead. Over, the last three months, the company has been observed to trade below the broader industry. Nevertheless, we look forward to the expected synergy from the LDR Holding acquisition, which should broaden and complement the company's musculoskeletal offering. We are also impressed by the strong strategic and financial goals which the combined entity expects to reach, now that the deal has been closed." (11/6/2017)
  • 2. Canaccord Genuity analysts commented, "SGEN reported 1Q earnings and provided a pipeline update." (4/28/2017)
  • 3. Needham & Company LLC analysts commented, "We hosted a dinner and investor meetings with Dan Florin, Senior Vice President and CFO, and Bob Marshall, Treasurer and Vice President of Investor Relations this week in New York City. We think that the discussion was upbeat and highlighted ZBH's progress in addressing its manufacturing challenges, its non-recon business performance, margin opportunities, and cash flow outlook. The meetings reinforced our view that ZBH should be able to drive its revenue growth to sustainable mid-single digit growth with a combination of market growth in recon and above-market growth in its non-recon businesses. We reiterate our Strong Buy rating." (2/17/2017)

Who are some of Zimmer Biomet Holdings' key competitors?

Who are Zimmer Biomet Holdings' key executives?

Zimmer Biomet Holdings' management team includes the folowing people:

  • Daniel P. Florin, Interim Chief Executive Officer, Chief Financial Officer, Director (Age 53)
  • Robert D. Delps, President, Americas
  • Katarzyna Mazur-Hofsaess M.D. Ph.D., President, Europe, Middle East and Africa (Age 52)
  • Sang Yi, President, Asia Pacific (Age 54)
  • Chad F. Phipps, Senior Vice President, General Counsel, Secretary (Age 44)
  • Larry C. Glasscock, Independent Non-Executive Chairman of the Board (Age 69)
  • Christopher B. Begley, Independent Director (Age 65)
  • Betsy J. Bernard, Independent Director (Age 61)
  • Gail Koziara Boudreaux, Independent Director (Age 56)
  • Michael Farrell, Independent Director (Age 45)

Who owns Zimmer Biomet Holdings stock?

Zimmer Biomet Holdings' stock is owned by many different of institutional and retail investors. Top institutional shareholders include Longview Partners Guernsey LTD (3.71%), Nordea Investment Management AB (2.61%), American Century Companies Inc. (2.06%), Bank of New York Mellon Corp (1.36%), Ameriprise Financial Inc. (1.23%) and Wedge Capital Management L L P NC (0.72%). Company insiders that own Zimmer Biomet Holdings stock include Blackstone Capital Partners V, Chad F Phipps, Daniel E Williamson, Daniel P Florin, David A Jr Nolan, David C Dvorak, Sang Yi, Stuart G Kleopfer and Tony W Collins. View Institutional Ownership Trends for Zimmer Biomet Holdings.

Who sold Zimmer Biomet Holdings stock? Who is selling Zimmer Biomet Holdings stock?

Zimmer Biomet Holdings' stock was sold by a variety of institutional investors in the last quarter, including Investec Asset Management LTD, Ameriprise Financial Inc., Sterling Capital Management LLC, Boston Partners, Korea Investment CORP, Neuberger Berman Group LLC, Russell Investments Group Ltd. and First Manhattan Co.. Company insiders that have sold Zimmer Biomet Holdings company stock in the last year include Chad F Phipps, David A Jr Nolan, David C Dvorak, Sang Yi and Tony W Collins. View Insider Buying and Selling for Zimmer Biomet Holdings.

Who bought Zimmer Biomet Holdings stock? Who is buying Zimmer Biomet Holdings stock?

Zimmer Biomet Holdings' stock was acquired by a variety of institutional investors in the last quarter, including Longview Partners Guernsey LTD, Alyeska Investment Group L.P., Bank of New York Mellon Corp, Cramer Rosenthal Mcglynn LLC, Wells Fargo & Company MN, Nordea Investment Management AB, American Century Companies Inc. and Thompson Siegel & Walmsley LLC. View Insider Buying and Selling for Zimmer Biomet Holdings.

How do I buy Zimmer Biomet Holdings stock?

Shares of Zimmer Biomet Holdings can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Zimmer Biomet Holdings' stock price today?

One share of Zimmer Biomet Holdings stock can currently be purchased for approximately $112.24.

How big of a company is Zimmer Biomet Holdings?

Zimmer Biomet Holdings has a market capitalization of $22.67 billion and generates $7.6839 billion in revenue each year. The medical equipment provider earns $305.9 million in net income (profit) each year or $3.21 on an earnings per share basis. Zimmer Biomet Holdings employs 18,500 workers across the globe.

How can I contact Zimmer Biomet Holdings?

Zimmer Biomet Holdings' mailing address is 345 E Main St, WARSAW, IN 46580-2746, United States. The medical equipment provider can be reached via phone at +1-574-2676131 or via email at [email protected]


MarketBeat Community Rating for Zimmer Biomet Holdings (NYSE ZBH)
Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  555 (Vote Outperform)
Underperform Votes:  424 (Vote Underperform)
Total Votes:  979
MarketBeat's community ratings are surveys of what our community members think about Zimmer Biomet Holdings and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Ratings for Zimmer Biomet Holdings (NYSE:ZBH) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Sell Rating, 6 Hold Ratings, 14 Buy Ratings, 1 Strong Buy Rating
Consensus Rating:Buy (Score: 2.68)
Consensus Price Target: $135.40 (20.63% upside)
Consensus Price Target History for Zimmer Biomet Holdings (NYSE:ZBH)
Price Target History for Zimmer Biomet Holdings (NYSE:ZBH)
Analysts' Ratings History for Zimmer Biomet Holdings (NYSE:ZBH)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
11/14/2017Deutsche Bank AGUpgradeHold -> Buy$128.00N/AView Rating Details
11/9/2017Edward JonesUpgradeHold -> BuyN/AView Rating Details
11/7/2017Royal Bank Of CanadaLower Price TargetOutperform$125.00N/AView Rating Details
11/3/2017Stifel NicolausReiterated RatingHold$120.00N/AView Rating Details
11/3/2017Jefferies Group LLCReiterated RatingBuy$136.00N/AView Rating Details
11/2/2017Morgan StanleyLower Price TargetOverweight$146.00 -> $136.00N/AView Rating Details
11/2/2017BMO Capital MarketsLower Price TargetOutperform$140.00 -> $135.00N/AView Rating Details
11/2/2017Piper Jaffray CompaniesDowngradeOverweight -> NeutralN/AView Rating Details
11/1/2017SunTrust Banks, Inc.Set Price TargetBuy$136.00N/AView Rating Details
8/24/2017GabelliInitiated CoverageBuy$142.00LowView Rating Details
8/14/2017Oppenheimer Holdings, Inc.Set Price TargetBuy$137.00LowView Rating Details
7/28/2017Leerink SwannBoost Price TargetOutperform$141.00 -> $146.00LowView Rating Details
7/28/2017Canaccord GenuityDowngradeBuy -> Hold$141.00 -> $135.00MediumView Rating Details
7/27/2017Cantor FitzgeraldSet Price TargetHold$137.00LowView Rating Details
7/14/2017Bank of America CorporationReiterated RatingBuy -> Buy$158.00MediumView Rating Details
7/14/2017Wells Fargo & CompanyReiterated RatingMarket WeightHighView Rating Details
7/12/2017Needham & Company LLCReiterated RatingStrong-Buy$153.00LowView Rating Details
7/12/2017GuggenheimUpgradeNeutral -> Buy$157.00MediumView Rating Details
6/9/2017Citigroup Inc.Boost Price TargetNeutral$108.00 -> $130.00LowView Rating Details
5/16/2017The Goldman Sachs Group, Inc.Initiated CoverageSell -> Sell$92.00HighView Rating Details
2/1/2017Robert W. BairdReiterated RatingOutperform$130.00 -> $136.00N/AView Rating Details
1/5/2017J P Morgan Chase & CoSet Price TargetBuy$134.00N/AView Rating Details
11/8/2016Northcoast ResearchDowngradeBuy -> NeutralN/AView Rating Details
9/22/2016ArgusReiterated RatingBuy$140.00N/AView Rating Details
8/23/2016Barclays PLCBoost Price TargetOverweight$140.00 -> $145.00N/AView Rating Details
7/29/2016JMP SecuritiesBoost Price TargetMarket Outperform$131.00 -> $145.00N/AView Rating Details
5/16/2016Sterne Agee CRTReiterated RatingBuyN/AView Rating Details
3/17/2016NomuraInitiated CoverageBuy$123.00N/AView Rating Details
1/31/2016William BlairReiterated RatingOutperformN/AView Rating Details
1/29/2016Northland SecuritiesLower Price Target$109.00 -> $105.00N/AView Rating Details
(Data available from 11/17/2015 forward)

Earnings

Earnings History for Zimmer Biomet Holdings (NYSE:ZBH)
Earnings by Quarter for Zimmer Biomet Holdings (NYSE:ZBH)
Earnings History by Quarter for Zimmer Biomet Holdings (NYSE ZBH)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
1/29/2018N/AView Earnings Details
11/1/2017Q3 2017$1.74$1.72$1.83 billion$1.82 billionViewN/AView Earnings Details
7/27/2017Q2 2017$2.10$2.08$1.95 billion$1.95 billionViewN/AView Earnings Details
4/27/2017Q1 2017$2.11$2.13$1.96 billion$1.98 billionViewN/AView Earnings Details
1/31/2017Q416$2.11$2.14$1.98 billion$2.01 billionViewListenView Earnings Details
10/31/2016Q316$1.79$1.79$950.20 million$1.83 billionViewListenView Earnings Details
7/28/2016Q216$1.97$2.02$1.90 billion$1.93 billionViewListenView Earnings Details
4/28/2016Q116$1.93$2.00$1.88 billion$1.90 billionViewListenView Earnings Details
1/28/2016Q415$2.04$2.09$1.96 billion$1.98 billionViewListenView Earnings Details
10/29/2015Q315$1.56$1.64$1.76 billion$1.76 billionViewListenView Earnings Details
4/30/2015Q115$1.54$1.58$1.15 billion$1.13 billionViewN/AView Earnings Details
1/29/2015Q414$1.71$0.91$1.25 billion$1.22 billionViewN/AView Earnings Details
10/23/2014Q314$1.00$0.96$1.10 billion$1.11 billionViewListenView Earnings Details
7/24/2014Q214$1.49$1.49$1.21 billion$1.18 billionViewN/AView Earnings Details
4/24/2014Q114$1.47$1.50$1.18 billion$1.16 billionViewListenView Earnings Details
1/31/2014Q114$1.62$1.36$1.22 billion$1.24 billionViewN/AView Earnings Details
10/24/2013Q313$1.24$1.25$1.06 billion$1.07 billionViewN/AView Earnings Details
7/25/2013Q2 2013$1.44$1.43$1.15 billion$1.17 billionViewN/AView Earnings Details
4/25/2013Q1 2013$1.40$1.41$1.14 billion$1.14 billionViewN/AView Earnings Details
1/31/2013Q4 2012$1.49$1.51$1.17 billion$1.18 billionViewN/AView Earnings Details
10/25/2012$1.13$1.15ViewN/AView Earnings Details
7/26/2012$1.32$1.34ViewN/AView Earnings Details
4/26/2012$1.30$1.30ViewN/AView Earnings Details
1/26/2012$1.34$1.36ViewN/AView Earnings Details
10/27/2011$1.03$1.04ViewN/AView Earnings Details
7/27/2011$1.19$1.21ViewN/AView Earnings Details
4/28/2011$1.12$1.19ViewN/AView Earnings Details
1/27/2011$1.19$1.21ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Zimmer Biomet Holdings (NYSE:ZBH)
2017 EPS Consensus Estimate: $8.09
2018 EPS Consensus Estimate: $8.19
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20175$2.10$2.14$2.11
Q2 20176$2.08$2.18$2.12
Q3 20176$1.71$1.93$1.77
Q4 20176$2.08$2.11$2.10
Q1 20185$1.92$2.10$2.00
Q2 20185$1.97$2.14$2.02
Q3 20185$1.84$1.98$1.91
Q4 20185$2.23$2.29$2.26
(Data provided by Zacks Investment Research)

Dividends

Current Dividend Information for Zimmer Biomet Holdings (NYSE:ZBH)
Most Recent Dividend:10/27/2017
Annual Dividend:$0.96
Dividend Yield:0.86%
Dividend Growth:0.00% (3 Year Average)
Payout Ratio:29.91% (Trailing 12 Months of Earnings)
11.96% (Based on This Year's Estimates)
11.59% (Based on Next Year's Estimates)
Frequency:Quarterly Dividend
Dividend Payments by Quarter for Zimmer Biomet Holdings (NYSE:ZBH)

Dividend History by Quarter for Zimmer Biomet Holdings (NYSE ZBH)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
8/7/2017quarterly$0.240.83%9/21/20179/22/201710/27/2017
5/30/2017quarterly$0.240.81%6/21/20176/23/20177/28/2017
3/1/2017quarterly$0.240.81%3/29/20173/31/20174/28/2017
12/19/2016quarterly$0.240.94%12/28/201612/30/20161/27/2017
8/23/2016quarterly$0.240.74%9/21/20169/23/201610/28/2016
5/23/2016quarterly$0.246/22/20166/24/20167/29/2016
2/24/2016quarterly$0.240.99%3/29/20163/31/20164/29/2016
12/14/2015quarterly$0.220.87%12/29/201512/31/20151/29/2016
8/24/2015quarterly$0.220.9%9/28/20159/30/201510/30/2015
5/5/2015quarterly$0.220.8%5/13/20155/15/20157/14/2015
2/24/2015quarterly$0.220.73%3/4/20153/6/20154/24/2015
12/15/2014quarterly$0.220.81%12/24/201412/29/20141/30/2015
8/26/2014quarterly$0.220.87%9/24/20149/26/201410/31/2014
5/23/2014quarterly$0.220.86%6/25/20146/27/20147/25/2014
3/5/2014quarterly$0.220.9%3/26/20143/28/20144/25/2014
12/16/2013quarterly$0.200.88%12/24/201312/27/20131/31/2014
9/9/2013quarterly$0.200.99%9/25/20139/27/201310/25/2013
6/14/2013quarterly$0.201.03%6/26/20136/28/20137/26/2013
3/8/2013quarterly$0.201.06%3/26/20133/29/20134/26/2013
12/14/2012quarterly$0.181.06%12/24/201212/27/20121/25/2013
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Zimmer Biomet Holdings (NYSE ZBH)
Insider Ownership Percentage: 1.07%
Institutional Ownership Percentage: 85.44%
Insider Trades by Quarter for Zimmer Biomet Holdings (NYSE:ZBH)
Insider Trades by Quarter for Zimmer Biomet Holdings (NYSE:ZBH)
Insider Trades by Quarter for Zimmer Biomet Holdings (NYSE ZBH)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/31/2017Tony W. CollinsVPSell16,986$121.74$2,067,875.64View SEC Filing  
6/12/2017Sang YiInsiderSell17,731$124.56$2,208,573.36View SEC Filing  
5/5/2017Chad F. PhippsVPSell6,200$116.76$723,912.00View SEC Filing  
4/27/2017David C DvorakInsiderSell87,331$116.47$10,171,441.57View SEC Filing  
3/20/2017David C DvorakInsiderSell1,040$121.63$126,495.20View SEC Filing  
12/2/2016David A. Jr. NolanInsiderSell5,050$101.11$510,605.50View SEC Filing  
9/8/2016Daniel E WilliamsonInsiderSell2,716$129.96$352,971.36View SEC Filing  
8/23/2016Stuart G KleopferInsiderSell3,397$129.71$440,624.87View SEC Filing  
8/12/2016Tony W. CollinsVPSell1,287$129.16$166,228.92View SEC Filing  
8/9/2016Stuart G KleopferInsiderSell533$132.71$70,734.43View SEC Filing  
8/1/2016David A. Jr. NolanInsiderSell25,255$130.77$3,302,596.35View SEC Filing  
7/11/2016Daniel P FlorinCFOSell15,000$124.98$1,874,700.00View SEC Filing  
6/14/2016Tony W CollinsCAOSell3,611$116.43$420,428.73View SEC Filing  
6/9/2016Stuart G KleopferInsiderSell11,000$119.45$1,313,950.00View SEC Filing  
4/14/2016Daniel P FlorinCFOSell10,000$114.98$1,149,800.00View SEC Filing  
4/12/2016Daniel P FlorinCFOSell12,000$110.00$1,320,000.00View SEC Filing  
3/21/2016David C DvorakCEOSell1,540$104.16$160,406.40View SEC Filing  
2/10/2016Blackstone Capital Partners VMajor ShareholderSell7,351,708$95.91$705,102,314.28View SEC Filing  
1/8/2016David C. DvorakCEOSell44,661$102.46$4,575,966.06View SEC Filing  
12/2/2015David A. Jr. NolaninsiderSell3,435$102.62$352,499.70View SEC Filing  
6/30/2015Adam Rudolph JohnsonInsiderSell30,600$110.34$3,376,404.00View SEC Filing  
6/29/2015Daniel E WilliamsonInsiderSell16,000$110.98$1,775,680.00View SEC Filing  
6/29/2015Daniel P FlorinCFOSell5,000$107.00$535,000.00View SEC Filing  
3/17/2015David C DvorakCEOSell1,300$115.55$150,215.00View SEC Filing  
12/5/2014David C DvorakCEOSell48,703$115.00$5,600,845.00View SEC Filing  
11/28/2014Chad F PhippsVPSell5,000$112.00$560,000.00View SEC Filing  
11/3/2014Katarzyna Mazur-HofsaessInsiderSell28,253$110.01$3,108,112.53View SEC Filing  
9/9/2014Stephen Hong Liang OoiInsiderSell40,768$102.78$4,190,135.04View SEC Filing  
8/26/2014James T CrinesCFOSell40,768$101.00$4,117,568.00View SEC Filing  
1/8/2014Jeffery MccaulleyInsiderSell21,286$96.00$2,043,456.00View SEC Filing  
1/7/2014Chad PhippsVPSell7,000$95.00$665,000.00View SEC Filing  
12/20/2013Jeffery MccaulleyInsiderSell21,286$93.00$1,979,598.00View SEC Filing  
12/3/2013Jeffery MccaulleyInsiderSell2,713$90.12$244,495.56View SEC Filing  
11/15/2013Derek DavisCAOSell3,500$90.20$315,700.00View SEC Filing  
11/14/2013Chad PhippsVPSell7,800$90.00$702,000.00View SEC Filing  
11/14/2013David DvorakCEOSell64,763$90.00$5,828,670.00View SEC Filing  
11/14/2013Jeffery MccaulleyInsiderSell21,285$90.00$1,915,650.00View SEC Filing  
9/13/2013Katarzyna Mazur-HofsaessInsiderSell4,890$81.38$397,948.20View SEC Filing  
8/1/2013James T CrinesCFOSell46,200$84.56$3,906,672.00View SEC Filing  
8/1/2013Stephen Hong Liang OoiInsiderSell38,500$84.27$3,244,395.00View SEC Filing  
7/29/2013Derek M DavisCAOSell3,725$83.78$312,080.50View SEC Filing  
7/29/2013Jeffery A MccaulleyInsiderSell112,255$83.40$9,362,067.00View SEC Filing  
7/19/2013Chad F PhippsVPSell6,000$83.00$498,000.00View SEC Filing  
5/8/2013Chad F PhippsVPSell5,000$77.26$386,300.00View SEC Filing  
4/30/2013James T CrinesCFOSell25,000$76.08$1,902,000.00View SEC Filing  
4/30/2013Jeffery A MccaulleyInsiderSell10,000$76.08$760,800.00View SEC Filing  
2/4/2013Derek M DavisCAOSell21,864$72.53$1,585,795.92View SEC Filing  
2/4/2013Jeffery A MccaulleyInsiderSell12,000$73.60$883,200.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Zimmer Biomet Holdings (NYSE:ZBH)
Latest Headlines for Zimmer Biomet Holdings (NYSE ZBH)
Source:
DateHeadline
What’s behind Zimmer Biomet’s Recent Stock Downtrend?What’s behind Zimmer Biomet’s Recent Stock Downtrend?
finance.yahoo.com - November 16 at 10:13 AM
Zimmer Biomet Holdings, Inc. (ZBH) Given Consensus Recommendation of "Hold" by BrokeragesZimmer Biomet Holdings, Inc. (ZBH) Given Consensus Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - November 16 at 5:42 AM
Zimmer Biomet Lowered 2017 Guidance Again amid Major HeadwindsZimmer Biomet Lowered 2017 Guidance Again amid Major Headwinds
finance.yahoo.com - November 13 at 8:20 PM
Ankle Replacements Take Off as Devices Appear DurableAnkle Replacements Take Off as Devices Appear Durable
finance.yahoo.com - November 13 at 10:24 AM
Zimmer Biomet’s Plan to Revive Growth amid Supply DisruptionsZimmer Biomet’s Plan to Revive Growth amid Supply Disruptions
finance.yahoo.com - November 13 at 10:24 AM
Attractive Product Pipeline Could Revive Zimmer Biomet’s GrowthAttractive Product Pipeline Could Revive Zimmer Biomet’s Growth
finance.yahoo.com - November 13 at 10:24 AM
Key Launches Expected to Drive Zimmer Biomet’s SalesKey Launches Expected to Drive Zimmer Biomet’s Sales
finance.yahoo.com - November 12 at 1:46 PM
Asia-Pacific Still Zimmer Biomet’s Strongest GeographyAsia-Pacific Still Zimmer Biomet’s Strongest Geography
finance.yahoo.com - November 12 at 1:46 PM
Zimmer Biomet to Present at Jefferies 2017 London Healthcare ConferenceZimmer Biomet to Present at Jefferies 2017 London Healthcare Conference
finance.yahoo.com - November 9 at 10:47 AM
Q4 2017 EPS Estimates for Zimmer Biomet Holdings, Inc. Cut by Analyst (ZBH)Q4 2017 EPS Estimates for Zimmer Biomet Holdings, Inc. Cut by Analyst (ZBH)
www.americanbankingnews.com - November 8 at 12:50 PM
Zimmer Biomet Holdings, Inc.’s (ZBH) Upgraded to HoldZimmer Biomet Holdings, Inc.’s (ZBH) Upgraded to Hold
investorplace.com - November 7 at 4:18 PM
SunTrust Banks Equities Analysts Reduce Earnings Estimates for Zimmer Biomet Holdings, Inc. (ZBH)SunTrust Banks Equities Analysts Reduce Earnings Estimates for Zimmer Biomet Holdings, Inc. (ZBH)
www.americanbankingnews.com - November 7 at 5:52 AM
Zimmer Biomet Holdings, Inc. (ZBH) Stock Rating Lowered by Zacks Investment ResearchZimmer Biomet Holdings, Inc. (ZBH) Stock Rating Lowered by Zacks Investment Research
www.americanbankingnews.com - November 6 at 2:54 PM
Analysts Issue Forecasts for Zimmer Biomet Holdings, Inc.s FY2019 Earnings (ZBH)Analysts Issue Forecasts for Zimmer Biomet Holdings, Inc.'s FY2019 Earnings (ZBH)
www.americanbankingnews.com - November 6 at 2:20 PM
FY2017 EPS Estimates for Zimmer Biomet Holdings, Inc. (ZBH) Cut by AnalystFY2017 EPS Estimates for Zimmer Biomet Holdings, Inc. (ZBH) Cut by Analyst
www.americanbankingnews.com - November 6 at 1:22 AM
Oppenheimer Holdings Analysts Cut Earnings Estimates for Zimmer Biomet Holdings, Inc. (ZBH)Oppenheimer Holdings Analysts Cut Earnings Estimates for Zimmer Biomet Holdings, Inc. (ZBH)
www.americanbankingnews.com - November 6 at 1:22 AM
Zimmer Biomet Holdings, Inc. (ZBH) Forecasted to Post FY2017 Earnings of $8.01 Per ShareZimmer Biomet Holdings, Inc. (ZBH) Forecasted to Post FY2017 Earnings of $8.01 Per Share
www.americanbankingnews.com - November 6 at 1:22 AM
Equities Analysts Set Expectations for Zimmer Biomet Holdings, Inc.s FY2017 Earnings (ZBH)Equities Analysts Set Expectations for Zimmer Biomet Holdings, Inc.'s FY2017 Earnings (ZBH)
www.americanbankingnews.com - November 6 at 1:22 AM
Research Analysts Issue Forecasts for Zimmer Biomet Holdings, Inc.s FY2017 Earnings (ZBH)Research Analysts Issue Forecasts for Zimmer Biomet Holdings, Inc.'s FY2017 Earnings (ZBH)
www.americanbankingnews.com - November 6 at 1:22 AM
Zimmer Biomet Holdings (ZBH) "Buy" Rating Reiterated at Jefferies Group LLCZimmer Biomet Holdings' (ZBH) "Buy" Rating Reiterated at Jefferies Group LLC
www.americanbankingnews.com - November 5 at 4:56 PM
Zimmer Biomet Holdings, Inc. – Value Analysis (NYSE:ZBH) : November 3, 2017Zimmer Biomet Holdings, Inc. – Value Analysis (NYSE:ZBH) : November 3, 2017
finance.yahoo.com - November 5 at 8:27 AM
Zimmer Biomet Holdings, Inc. (ZBH) Earns "Hold" Rating from Stifel NicolausZimmer Biomet Holdings, Inc. (ZBH) Earns "Hold" Rating from Stifel Nicolaus
www.americanbankingnews.com - November 3 at 5:14 PM
Zimmer Biomet Holdings, Inc. (ZBH) Price Target Cut to $135.00Zimmer Biomet Holdings, Inc. (ZBH) Price Target Cut to $135.00
www.americanbankingnews.com - November 2 at 6:28 PM
Morgan Stanley Cuts Zimmer Biomet Holdings, Inc. (ZBH) Price Target to $136.00Morgan Stanley Cuts Zimmer Biomet Holdings, Inc. (ZBH) Price Target to $136.00
www.americanbankingnews.com - November 2 at 6:28 PM
Zimmer Biomet Holdings (ZBH) Misses Q3 EPS by 4c, Miss on Revenues; Lowers FY17 EPS Guidance Below Consensus; FY17 Revenue Outlook Below ConsensusZimmer Biomet Holdings (ZBH) Misses Q3 EPS by 4c, Miss on Revenues; Lowers FY17 EPS Guidance Below Consensus; FY17 Revenue Outlook Below Consensus
www.streetinsider.com - November 2 at 11:59 AM
Edited Transcript of ZBH earnings conference call or presentation 1-Nov-17 12:00pm GMTEdited Transcript of ZBH earnings conference call or presentation 1-Nov-17 12:00pm GMT
finance.yahoo.com - November 2 at 11:59 AM
Estee Lauder, US Steel jump but Envision Healthcare tumblesEstee Lauder, US Steel jump but Envision Healthcare tumbles
finance.yahoo.com - November 2 at 11:58 AM
Zimmer Biomet Holdings, Inc. breached its 50 day moving average in a Bearish Manner : ZBH-US : November 2, 2017Zimmer Biomet Holdings, Inc. breached its 50 day moving average in a Bearish Manner : ZBH-US : November 2, 2017
finance.yahoo.com - November 2 at 11:58 AM
FY2017 EPS Estimates for Zimmer Biomet Holdings, Inc. Reduced by Jefferies Group (ZBH)FY2017 EPS Estimates for Zimmer Biomet Holdings, Inc. Reduced by Jefferies Group (ZBH)
www.americanbankingnews.com - November 2 at 6:48 AM
Zimmer Biomet Holdings, Inc. (ZBH) Given a $136.00 Price Target at SunTrust Banks, Inc.Zimmer Biomet Holdings, Inc. (ZBH) Given a $136.00 Price Target at SunTrust Banks, Inc.
www.americanbankingnews.com - November 1 at 3:22 PM
Zimmer Biomet Holdings, Inc. (ZBH) Announces  Earnings ResultsZimmer Biomet Holdings, Inc. (ZBH) Announces Earnings Results
www.americanbankingnews.com - November 1 at 11:36 AM
Zimmer Biomet Holdings, Inc. 2017 Q3 - Results - Earnings Call SlidesZimmer Biomet Holdings, Inc. 2017 Q3 - Results - Earnings Call Slides
seekingalpha.com - November 1 at 11:09 AM
Zimmer Biomets (ZBH) Q3 Earnings Lag Estimates, View DownZimmer Biomet's (ZBH) Q3 Earnings Lag Estimates, View Down
www.zacks.com - November 1 at 11:09 AM
Zimmer misses Street 3Q forecastsZimmer misses Street 3Q forecasts
finance.yahoo.com - November 1 at 11:08 AM
Zimmer Biomet (ZBH) Misses Q3 Earnings, Meets Sales EstimateZimmer Biomet (ZBH) Misses Q3 Earnings, Meets Sales Estimate
finance.yahoo.com - November 1 at 11:08 AM
Zimmer Biomet Holdings, Inc. (ZBH) Updates FY17 Earnings GuidanceZimmer Biomet Holdings, Inc. (ZBH) Updates FY17 Earnings Guidance
www.americanbankingnews.com - November 1 at 9:47 AM
Zimmer Biomet Holdings, Inc. (ZBH) Issues Q4 Earnings GuidanceZimmer Biomet Holdings, Inc. (ZBH) Issues Q4 Earnings Guidance
www.americanbankingnews.com - November 1 at 9:37 AM
Shrinking Industry Group Rank Makes Zimmer Biomet Holdings, Inc. (ZBH) a SellShrinking Industry Group Rank Makes Zimmer Biomet Holdings, Inc. (ZBH) a Sell
investorplace.com - October 31 at 11:57 AM
Corporate News Blog - Zimmer Biomet Launches Vitality(R)+ and Vital(TM) Spinal Fixation Systems in the USCorporate News Blog - Zimmer Biomet Launches Vitality(R)+ and Vital(TM) Spinal Fixation Systems in the US
finance.yahoo.com - October 27 at 7:55 AM
Zimmer Biomet Holdings (ZBH) Launches Vitality+ and Vital Spinal Fixation Systems in US - StreetInsider.comZimmer Biomet Holdings (ZBH) Launches Vitality+ and Vital Spinal Fixation Systems in US - StreetInsider.com
www.streetinsider.com - October 26 at 6:00 AM
Quant Score Makes Zimmer Biomet Holdings, Inc. (ZBH) a Sell - Investorplace.comQuant Score Makes Zimmer Biomet Holdings, Inc. (ZBH) a Sell - Investorplace.com
investorplace.com - October 26 at 6:00 AM
Zimmer Biomet Announces U.S. Launch of Vitality®+ and Vital™ Spinal Fixation SystemsZimmer Biomet Announces U.S. Launch of Vitality®+ and Vital™ Spinal Fixation Systems
finance.yahoo.com - October 26 at 6:00 AM
Zimmer Biomet Holdings (ZBH) & Hill-Rom Holdings (HRC) Financial ComparisonZimmer Biomet Holdings (ZBH) & Hill-Rom Holdings (HRC) Financial Comparison
www.americanbankingnews.com - October 25 at 2:54 PM
Will SET Arm Drive Zimmer Biomets (ZBH) Q3 Earnings? - NasdaqWill SET Arm Drive Zimmer Biomet's (ZBH) Q3 Earnings? - Nasdaq
www.nasdaq.com - October 24 at 12:56 PM
ETFs with exposure to Zimmer Biomet Holdings, Inc. : October 23, 2017ETFs with exposure to Zimmer Biomet Holdings, Inc. : October 23, 2017
finance.yahoo.com - October 24 at 12:56 PM
Will S.E.T. Arm Drive Zimmer Biomet's (ZBH) Q3 Earnings?Will S.E.T. Arm Drive Zimmer Biomet's (ZBH) Q3 Earnings?
finance.yahoo.com - October 24 at 12:56 PM
Quant Score Makes Zimmer Biomet Holdings, Inc. (ZBH) a SellQuant Score Makes Zimmer Biomet Holdings, Inc. (ZBH) a Sell
investorplace.com - October 24 at 12:39 PM
Zimmer Biomet Holdings, Inc. (ZBH) Set to Announce Earnings on MondayZimmer Biomet Holdings, Inc. (ZBH) Set to Announce Earnings on Monday
www.americanbankingnews.com - October 23 at 5:38 AM
Zimmer Biomet Holdings, Inc. (ZBH) Receives Consensus Recommendation of "Hold" from AnalystsZimmer Biomet Holdings, Inc. (ZBH) Receives Consensus Recommendation of "Hold" from Analysts
www.americanbankingnews.com - October 22 at 6:38 AM
Head to Head Survey: T2 Biosystems (TTOO) and Zimmer Biomet Holdings (ZBH)Head to Head Survey: T2 Biosystems (TTOO) and Zimmer Biomet Holdings (ZBH)
www.americanbankingnews.com - October 19 at 10:32 PM

Social Media

Financials

Chart

Zimmer Biomet Holdings (NYSE ZBH) Chart for Friday, November, 17, 2017
Loading chart…

This page was last updated on 11/17/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.